{"organizations": [], "uuid": "b98f85adf17ade170c92c57b2e68c3fe0cbecade", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mynd-analytics-awarded-canadian-pa/brief-mynd-analytics-awarded-canadian-patent-on-neuromodulation-platformpredicts-patients-likely-to-respond-to-tms-for-treating-depression-idUSFWN1PY11D", "country": "US", "domain_rank": 408, "title": "BRIEF-MYnd Analytics Awarded Canadian Patent On Neuromodulation Platform Predicts Patients Likely To Respond To TMS For Treating Depression", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.764, "site_type": "news", "published": "2018-02-08T20:39:00.000+02:00", "replies_count": 0, "uuid": "b98f85adf17ade170c92c57b2e68c3fe0cbecade"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mynd-analytics-awarded-canadian-pa/brief-mynd-analytics-awarded-canadian-patent-on-neuromodulation-platformpredicts-patients-likely-to-respond-to-tms-for-treating-depression-idUSFWN1PY11D", "ord_in_thread": 0, "title": "BRIEF-MYnd Analytics Awarded Canadian Patent On Neuromodulation Platform Predicts Patients Likely To Respond To TMS For Treating Depression", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "neutral"}, {"name": "mynd analytics inc", "sentiment": "neutral"}, {"name": "tms", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - MYnd Analytics Inc:\n* MYND ANALYTICS AWARDED CANADIAN PATENT ON NEUROMODULATION PLATFORM; PREDICTS PATIENTS LIKELY TO RESPOND TO TMS FOR TREATING DEPRESSION Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T20:39:00.000+02:00", "crawled": "2018-02-09T16:25:54.010+02:00", "highlightTitle": ""}